Replies to post #203104 on Biotech Values

[DewDiligence]

SNY/REGN—Dupilumab PDUFA date for treatment of atomic dermatitis is 3/29/17 (with priority review):

http://finance.yahoo.com/news/regeneron-sanofi-announce-dupilumab-biologics-050000647.html